Page 2 - Johnson Innovation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Third Rock, J&J neuroscience spinout Rapport outlines IPO plans

The new year burst of biotech IPOs may have sputtered out months ago, but Rapport is a reminder that companies are still willing to test the waters

Abe ceesayDavid bredtEli lillyExchange commissionRapport therapeuticsThird rockThird rock venturesArch venture partnersJohnson innovationFierce biotechSan diego basedMedicxi partner francesco de rubertis

J&J-Linked Rapport Therapeutics Files For IPO

J&J-Linked Rapport Therapeutics Files For IPO
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausJanssen pharmaceuticaBen glickmanDavid bredtExchange commissionGoldman sachsDow jones company incRapport therapeuticsNasdaq global marketJohnson innovationThird rockChief scientific officer david bredtThird rock venturesDow jones

Rapid Novor teams up with PMCC to evaluate EasyM™ for multiple myeloma minimal residual disease monitoring

Rapid Novor teams up with PMCC to evaluate EasyM™ for multiple myeloma minimal residual disease monitoring
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Liqiang yangNovor incmayJanssen incRapid novor incPrincess margaret cancer centreClinical laboratory improvement amendmentsFrom rapid novor incmayNovor incRapid novorChief strategy officerJohnson innovation

Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates

Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New havenUnited statesResearch development rd expensesExchange commissionJohnson companyRallybio corporation nasdaqJjdc incMomenta pharmaceuticals incReports first quarterProvides businessStephen udenChief executive officerBusiness highlightsUpcoming milestonesMomenta pharmaceuticalsJohnson innovation

ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator

ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomWestern australiaChris gardnerChristophe demaisonKirrily davisSue charlesTrademark officeMinderoo foundationUs department of defenceKey patent coveringFirst in class antiviral innateBrandon capitalJohnson innovation